Le Lézard
Classified in: Covid-19 virus
Subjects: Survey, Economic News/Analysis

Best's Special Report: U.S. Publicly Traded Life/Annuity Insurers' Revenues Off 12% in 2022


Premium growth for publicly traded U.S. life/annuity (L/A) insurance companies continued to recover in 2022, but was countered by declines in investment and fee income that drove total GAAP revenue down by 12% to $291.5 billion, according to a new AM Best report.

According to the Best's Special Report, another factor contributing to the revenue decline was $22.9 billion in realized losses, which were reported at all but three of the 18 companies used in the analysis. More than half of these companies saw an increase in premium revenue, while nearly all saw a drop in fee income, as declines in assets under management were more widespread.

"Many of the publicly traded life insurance companies have substantially reduced their product offerings in recent years due to the low interest rate environment, which made achieving targeted profit margins difficult," AM Best Associate Director Jason Hopper said. "Because of the COVID-19 pandemic, consumers have gravitated toward protection products such as indexed universal life."

The report also notes that with rising interest rates in 2022, L/A insurers ramped up fixed annuity production and were able to invest in higher-yielding securities and offer higher crediting rates. However, carriers began to pull back on fixed annuity sales in the latter half of 2022 to conserve capital and focus on building a more diverse product offering.

Other report highlights include:

To access the full copy of this special report, "Premiums Grow, Revenue Drops for Public Life/Annuity GAAP Insurers," please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=330627.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2023 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

3 jui 2024
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. between March 9, 2023 and February 29, 2024, both dates inclusive (the "Class Period"), of the important August 6, 2024 lead plaintiff...

3 jui 2024
The global feminine hygiene wash market  size is estimated to grow by USD 124.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 5.17%  during the forecast period.  Advertising and promotion of...

3 jui 2024
The global marine loading arms market size is estimated to grow by USD 65.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.43%  during the forecast period. Rise in demand for oil and gas...

3 jui 2024
The global payment gateways market size is estimated to grow by USD 11.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 13.42%  during the forecast period.  High adoption of contactless payment...

3 jui 2024
The global wellness real estate market size is estimated to grow by USD 1.26 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 32.14% during the forecast period. Rising demand for wellness real estate from...

3 jui 2024
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the...



News published on and distributed by: